According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current revenue (TTM ) is $0.11 Billion USD. In 2024 the company made a revenue of $0.10 Billion USD.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.